Software/Technology

Combining FDA, notified body and industry perspectives to shape the future of medical device regulations

Immuno-Oncology (IO) 360° takes a strategic look at the business and scientific aspects of Immuno-Oncology.  With significant in-put from Lead Advisors Dr. Axel Hoos (former CEO of Scorpion Therapeutics) and Dr. James Gulley (NCI,) the conference examines the current landscape, and reports on the latest advancements in IO to improve and accelerate clinical trials. The audience is comprised of roughly 500 top executives at Pharma companies and Biotechs, as well as the financial community, consultants and leading research organizations in the field of Immuno-Oncology.  

The 2022 ISPE Annual Meeting & Expo will usher in a revitalized focus on excellence, modernization, and harmonization in pharmaceutical science and manufacturing across the globe, offering pharma professionals the opportunity to engage in industry-critical conversations. A comprehensive education program provides attendees with technical sessions on the latest developments in supply chain, operations, facilities, equipment, information systems, product development, production systems, quality systems, regulatory guidance and cutting-edge industry innovations. This signature event draws pharmaceutical and biopharmaceutical professionals at all levels of the industry from emerging leaders to the most senior executives in drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies. The conference Partner Showcase presents a large offering of the latest technologies and services for the pharmaceutical industry.

Returning for its seventh year, LSX’s Inv€$tival Showcase directly connects life science and healthcare corporates to global capital and deal-makers. A multi-streamed showcase of early, growth stage and public life science and health technology companies, Investival Showcase provides an unrivalled opportunity to pitch, profile and connect with investors and partners brought together during the biggest week in European life science investment.

The ESMO Congress is the yearly appointment in Europe for nearly 30,000 clinicians, researchers, oncology nurses, patient advocates, journalists, and representatives of the pharmaceutical industry from all over the world to get together, learn about the latest advances in oncology, and translate science into better cancer patient care. Medical/clinical oncologists, basic translational researchers, oncology nurses, all other oncology professionals, patient advocates, journalists, healthcare industry representatives, policy decision makers, regulators.

The ERS Congress is the once-a-year occasion when the world’s respiratory experts come together, to present and discuss the latest scientific and clinical advances across the entire field of respiratory medicine. It welcomes a global audience of respiratory focused professionals inclusive of clinicians, scientists and researchers, and allied healthcare professionals. As the ERS Congress reaches its 32nd year, we invite you to register for this year’s event – our first to offer both in-person or online attendance.

Recognized as one of the top 50 medical meetings by HCEA, Digestive Disease Week® (DDW) is the world’s largest gathering of physicians, researchers and industry in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

The Global Clinical Trials Connect 2023 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.

The CNS Summit has become the premiere event for all those involved in clinical development to meet, network, and participate in initiatives that will shape the future. The summit is a platform for change and a community passionate about shaping the future, with a focus on collaboration, innovation, and technology. The mission is to have a positive impact on the success of clinical development programs. Join the pharma and biotech R&D leaders, the top tech companies involved in clinical development and healthcare innovation, investigator sites, service companies, and the regulators from FDA and EMA.

Capture the unmatched potential of these versatile stem cells in regenerative medicine and cell therapy by advancing scale-up, differentiation and quality to reduce variability and ensure stable and robust cell lines. Gain valuable insights from industry experts, through exclusive talks and discussions, into approaches to transform your manufacturing processes by exploring technology innovations, leveraging automation and AI, evolving analytics and advancing cryopreservation.